Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western
world, with a prevalence of 20%. In a subgroup of patients, inflammation, ballooning …

Hepatocellular carcinoma (HCC) is the sixth most common cancer in world and third largest
cause of cancer-related deaths. The last few decades have witnessed the emergence of non …

Introduction and objectives Fatty liver disease is an important public health problem. Early
diagnosis is critical to lower its rate of progression to irreversible/terminal stages. This study …

This review evaluates the ability of the fibrosis index based on four factors (FIB-4) identifying
fibrosis stages, long-time prognosis in chronic liver disease, and short-time outcomes in …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver
disease worldwide with a reported prevalence ranging 6–33%, depending on the studied …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease
worldwide. It represents a range of disorders, including simple steatosis, nonalcoholic …

The limitations of liver biopsy have led to the development of indirect noninvasive models for
liver fibrosis assessment. We aimed to evaluate and compare the performance of 30 …

Methods For this meta-analysis, various databases including PubMed (MEDLINE),
EMBASE, OVID Medline and the Cochrane Library were systematically searched. After the …

Nonalcoholic fatty liver disease (NAFLD) is the commonest chronic liver disease and
includes simple steatosis and nonalcoholic steatohepatitis (NASH). Since NASH progresses …

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is
increasing at an alarming rate. Elevated liver enzymes are a primary reason to refer patients …